Biocon, Mylan launch insulin biosimilar in Australia

The biotechnology major and pharmaceutical company Mylan N V announced the launch of their insulin biosimilar Semglee.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2nSFSpI
via IFTTT